Oberweis Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Oberweis Asset Management's ADPT Position: Q2 2026 in Review
Oberweis Asset Management increased its Adaptive Biotechnologies (ADPT) stake by 56% in Q2 2026, buying an estimated $6.92M and bringing the position to 1,258,751 shares worth $27M. The position accounts for 0.56% of the portfolio, ranked #65.
Oberweis Asset Management first reported a position in ADPT in Q2 2025 and has held it in 5 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Oberweis Asset Management held 1,258,751 shares of Adaptive Biotechnologies worth $27M as of Q2 2026.
- Oberweis Asset Management bought 451,800 Adaptive Biotechnologies shares in Q2 2026, an estimated $6.92M.
- Adaptive Biotechnologies made up 0.56% of Oberweis Asset Management's portfolio in Q2 2026, its #65 holding.
- Oberweis Asset Management first reported a position in Adaptive Biotechnologies in Q2 2025 and has held it in 5 quarters since.
- 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Oberweis Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.